US Stock MarketDetailed Quotes
METXF ME THERAPEUTICS HOLDINGS INC
- 2.947
- 0.0000.00%
15min DelayClose Aug 9 16:00 ET
74.24MMarket Cap-84.21P/E (TTM)
0.000High0.000Low0Volume0.000Open2.947Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)25.19MShares2.94752wk High62.71P/B74.24MFloat Cap2.94752wk Low--Dividend TTM25.19MShs Float2.947Historical High--Div YieldTTM0.00%Amplitude2.947Historical Low--Avg Price1Lot Size
About ME THERAPEUTICS HOLDINGS INC Company
ME Therapeutics Holdings, Inc. provides biotechnology and pharmaceutical services. It engages in research and development of cancer fighting drugs in the field of immuno-oncology (IO). ME Therapeutics Holdings develops drug candidates that can increase the efficacy of current IO drugs by targeting suppressive myeloid cells which are known to hinder the effectiveness of current IO treatments. The company was founded on November 9, 2021 and is headquartered in Vancouver, Canada.
Company Profile
SymbolMETXF
Company NameME THERAPEUTICS HOLDINGS INC
Founded2021
MarketPink Market
Employees1
Fiscal Year Ends08-31
Address177 Robson Street
CityVancouver
ProvinceBritish Columbia
CountryCanada
Zip CodeV6B 0N3
Phone1-236-516-7714
Company Executives
- Name
- Position
- Salary
- Salim Zulifkar Dhanji
- Director and Chief Executive Officer
- --
- Quinn Martin
- Chief Financial Officer
- --
- Kenneth Harder
- Independent Director
- --
- Karim Nanji
- Independent Director
- --
- John Priatel
- Independent Director
- --
- Jamil Kassam
- Corporate Secretary
- --
Heat List
US
Overall
Symbol
Price
% Chg
No Data